ArticleThe Journal of antibiotics2026
Pheophorbide A from Acrotrema agastyamalayanum: A potent antibiofilm agent targeting Proteus mirabilis.
Article in The Journal of antibiotics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The antibiofilm potential of the hexane extract of the rare and endangered endemic plant Acrotrema agastyamalayanum was determined against Proteus mirabilis. The biofilm-inhibitory activity of the hexane extract was evaluated by crystal violet quantification and light microscopy, which showed 89% inhibition at 11 mg/mL. The hexane extract exhibited 89% inhibition at 11 mg/mL as determined by crystal violet quantification and light microscopy. Pheophorbide A (PA), the active and most abundant chlorophyll derivative in the hexane extract, was identified based on its molecular ion fragmentation pattern using high-resolution liquid chromatography mass spectrometry (LC-MS/MS). PA exhibited concentration-dependent biofilm inhibition at 100 μg/mL and disrupted biofilm structure, leading to microcolony disintegration as observed under a microscope. PA significantly reduced the cell surface hydrophobicity (CSH) and extrapolymeric substances (EPS) secretion, underscoring its critical role in disrupting biofilm matrix and bacterial cell adhesion. This is the first study to report PA from A. agastyamalayanum with remarkable antibiofilm properties, highlighting its potential as a natural antibiofilm agent for controlling P. mirabilis infections.
Indexed as
Identifiers
42414672What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.